| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Mar 23, 2011 |
|||||||||
| Q3 FY11 | $0.56 | $0.56 | $3.65B | $3.65B |
NYSE |
||||
| - | $1.44 | $1.18 | $2.77B | $2.23B |
NYSE |
||||
| Q2 FY11 | $0.07 | $0.02 | $2.26B | $644.86M |
NASDAQ |
||||
| - | $0.36 | $0.35 | $519.60M | $516.54M |
NASDAQ |
||||
|
Steelcase
SCS
|
- | $0.11 | $0.08 | $622.90M | $453.02M |
NYSE |
|||
|
H.B. Fuller
FUL
|
- | $0.29 | $0.32 | $339.55M | $343.28M |
NYSE |
|||
|
Patriot National Bancorp
PNBK
|
- | -$1.06 | - | $8.66M | - |
NASDAQ |
|||
|
Plumas Bancorp
PLBC
|
- | $0.01 | - | $6.97M | - |
NASDAQ |
|||
|
iCAD
ICAD
|
- | -$0.30 | -$0.10 | $6.37M | $2.12M |
NASDAQ |
|||
|
BIO-key International
BKYI
|
- | -$2.65 | - | $564.81K | - |
NASDAQ |
|||
|
Pacific Biosciences of California
PACB
|
- | -$0.69 | - | $280K | - |
NASDAQ |
|||
|
Cyclacel Pharmaceuticals
CYCC
|
- | -$117.60 | -$168.00 | $138K | $200K |
NASDAQ |
|||
|
Empire Petroleum
EP
|
- | -$1.33 | - | - | - |
AMEX |
|||
| Show 3 more companies | |||||||||
